ADL5859

DRUG3 trials

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Conditions

Neuropathic PainOsteoarthritis of the KneePeripheral NeuropathyRheumatoid Arthritis

Phase 2

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

CompletedNCT00603265

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Neuropathic Pain, Peripheral Neuropathy

Start: 2007-11-30End: 2008-08-31Updated: 2015-07-01

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis

CompletedNCT00626275

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Rheumatoid Arthritis

Start: 2007-10-31End: 2008-09-30Updated: 2015-07-01

Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

CompletedNCT00979953

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Osteoarthritis of the Knee

Start: 2009-10-31End: 2010-06-30Updated: 2015-08-14